cannabidiol

Cambridge, Massachusetts, U.S., September 23, 2026 Flagship Pioneering has secured a first-of-its-kind contract worth up to $47 million over...

Toronto, Ontario, Canada, September 23, 2026 Cardiol Therapeutics has announced that its pivotal Phase III MAVERIC clinical trial evaluating...

Caesarea, Israel, August 20, 2026 IceCure Medical has announced an important clinical development for its minimally invasive ProSense® cryoablation...

Houston, Texas, August 20, 2026 FibroBiologics, Inc., a clinical-stage biotechnology company developing regenerative therapies based on fibroblast cells and...

Solana Beach, Calif., July 22, 2026 Artelo Biosciences announced the publication of a peer-reviewed review article in the British...

UNITED KINGDOM, June 17, 2026 Ananda Pharma Limited has announced that the first patient has been dosed in the...

DUBLIN, Ireland, May 27, 2026 Jazz Pharmaceuticals has announced the publication of pivotal Phase 3 HERIZON-GEA-01 trial results in...

HERZLIYA, Israel and CALGARY, Alberta, May 27, 2026 Innocan Pharma Corporation has reported strong first-quarter 2026 financial results, highlighting...

DUBLIN, Ireland, April 9, 2026 Jazz Pharmaceuticals plc has announced the presentation of six scientific abstracts, including one oral...